Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma
NCT ID: NCT01855802
Last Updated: 2017-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2013-04-30
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perceptions of Ophthalmologists Regarding Contemporary Presbyopia Management.
NCT04733014
Incidence and Progression of Glaucoma in the Tema Eye Survey Cohort
NCT02085850
Central Corneal Thickness in Glaucoma
NCT01023997
From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy
NCT04673604
Long-term Vascular, Functional and Morphological Changes in Glaucoma and Ocular Hypertensive Patients
NCT06827535
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Overall physician's empathy regarding generics in glaucoma
2. Physician's prescribing habits regarding generics in glaucoma
3. Physician's perceptions regarding generics cost-effectiveness in glaucoma
4. Physician's perceptions regarding adequacy of Greek regulatory authorities (generic market in glaucoma)
5. Physician's perceptions regarding adequacy of European regulatory authorities (generic market in glaucoma)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
25 Years
67 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Democritus University of Thrace
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Georgios Labiris
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Georgios Labiris, PhD
Role: PRINCIPAL_INVESTIGATOR
Democritus University of Thrace, Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Alexandroupolis
Alexandroupoli, Evros, Greece
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Labiris G, Fanariotis M, Kastanioti C, Alexias G, Protopapas A, Karampitsakos T, Niakas D. Greek Physicians' Perceptions on Generic Drugs in the Era of Austerity. Scientifica (Cairo). 2015;2015:251792. doi: 10.1155/2015/251792. Epub 2015 Sep 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EIT-GG-P
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.